Literature DB >> 15144849

Following the leader: fibrillization of alpha-synuclein and tau.

Mark Frasier1, Benjamin Wolozin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15144849     DOI: 10.1016/j.expneurol.2004.02.008

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  5 in total

1.  Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.

Authors:  Wendy Noble; Emmanuel Planel; Cindy Zehr; Vicki Olm; Jordana Meyerson; Farhana Suleman; Kate Gaynor; Lili Wang; John LaFrancois; Boris Feinstein; Mark Burns; Pavan Krishnamurthy; Yi Wen; Ratan Bhat; Jada Lewis; Dennis Dickson; Karen Duff
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-02       Impact factor: 11.205

2.  Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat.

Authors:  Robert J Phillips; Gary C Walter; Brittany E Ringer; Katherine M Higgs; Terry L Powley
Journal:  Exp Neurol       Date:  2009-08-05       Impact factor: 5.330

3.  The neurotoxin, MPP+, induces hyperphosphorylation of Tau, in the presence of alpha-Synuclein, in SH-SY5Y neuroblastoma cells.

Authors:  Tetyana Duka; Anita Sidhu
Journal:  Neurotox Res       Date:  2006-08       Impact factor: 3.911

Review 4.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

5.  Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.

Authors:  Tetyana Duka; Valeriy Duka; Jeffrey N Joyce; Anita Sidhu
Journal:  FASEB J       Date:  2009-04-15       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.